脊髓灰质炎病毒C3表位和C-myc十肽表位在细菌表面的表达

为了进一步验证载体pCSB136和pCSX72作为表面呈现载体的可行性 ,化学合成脊髓灰质炎病毒C3表位和C myc十肽表位的基因片段 ,并插入到上述载体的相应位点间 ,采用全菌PCR筛选到正向插入的重组子 ,全细胞ELISA和电镜观察显示 ,重组蛋白以杂和菌毛的形式得到了表达 ,并保持CS3和外源表位的抗原性 ,表明脊髓灰质炎病毒C3表位和C myc十肽表位在细菌表面得到了表达 ,证实载体pCSB136和pCSX72可用于外源表位的呈现 ,为构建基因工程活菌疫苗奠定了基础     

脊髓灰质炎病毒C3表位和C—myc＋肽表位在细菌表面的表达

为了进一步验证载体pCSB136和pCSX72作为表面呈现载体的可行性,化学合成脊髓灰质炎病毒C3表位和C-myc十肽有位的基因片段,并插入到上述载体的相应位点间,采用全菌PCR筛选到正向插入的重组子,全细胞ELISA和电镜观察显示,重组蛋白以杂和菌毛的形式得到了表达,并保持CS3和外源位的抗原性,表明脊髓灰质炎病毒C3表位和C-myc十肽捕位在细菌表面得到了表达,证实载体pCSB136和pCSX72可用于外源表位的呈现,为构建基因工程活苗疫苗奠定了基础。     

用人源肠毒素性大肠杆菌CS3菌毛构建新型呈现载体

根据对人源大肠杆菌菌毛CS3亚单位亲水性、表位、二级结构和柔韧性计算机预测结果,以CS3亚单位第72位氨基酸残基之后作为外源表位的插入位点,构建了一种新的表面呈现载体pCSX72。用该载体分别表达口蹄疫病毒（FMDV）的VP1表位和C-myc的十肽表位（410-419aa）。SDS-PAGE结果以及电镜和免疫电镜观察证明,插入的外源表位和CS3亚单位以杂合菌毛的形式呈现在菌体表面。ELISA检测结果表明,pCSX72表达的杂合蛋白的抗原性较之其他插入位点的载体要高得多。用重组细菌腹腔免疫小鼠,能够诱发机体对杂合蛋白的双重免疫应答。构建的表面呈现载体可望成为构建多价疫苗的有力工具。     

CS3菌毛可以作为异源抗原决定簇的表达载体

CS3是肠毒素源性大肠杆菌的菌毛蛋白 ,是一种很强的免疫原 .利用CS3菌毛作为异源抗原决定簇载体 ,在计算机分析预测CS3亚基的抗原表位区、二级结构的基础上 ,运用PCR定点突变在CS3亚基结构基因中引入了SacⅡ酶切位点序列 ,插入霍乱毒素B亚基抗原表位CTP3的DNA序列 ,构建了表达CS3/CTP3的重组菌株 .电镜和免疫电镜观察证明 ,CS3/CTP3以杂合菌毛的形式存在于菌体表面 .SDS聚丙烯酰胺凝胶电泳显示了CS3/CTP3杂合蛋白的存在 .口服和腹腔注射免疫Balb/c小鼠 ,该重组菌株可诱发抗CS3和抗CTP3的双重免疫应答 .结果表明CS3可以作为表达异源抗原决定簇的表达载体 ,可望成为研制口服粘膜免疫多价疫苗的新型系统     

CS3菌毛可以作为异源抗原决定簇的嵌合表达载体

CS3是肠毒素源性大肠杆菌的菌毛蛋白,是一种很强的免疫原。研究了利用CS3菌毛作为异源抗原决定簇载体的可能性。在计算机分析预测CS3亚基的抗原表位区、二级结构的基础上,运用PCR定点突变在CS3亚基结构基因中引入了SacⅡ酶切位点序列,插入编码霍乱毒素B亚基抗原表位CTP3的DNA序列,构建了表达CS3/CTP3的重组菌株。电镜和免疫电镜观察证明,CS3/CTP3以杂合菌毛的形式存在于菌体表面,SDS聚丙烯酰胺凝胶电泳显示了CS3/CTP3杂合蛋白的存在。口服和腹腔注射免疫Bal b/c小鼠,该重组菌株可诱发抗CS3和抗CTP3的双重免疫应答。结果表明CS3可以作为表达异源抗原决定簇的表达载体,可望成为研制口服粘膜免疫多价疫苗的新型系统。     

幽门螺杆菌Ure B串联融合表位的表面呈现表达

目的:应用表达载体pHIE3N表面呈现表达幽门螺杆菌Ure B串联融合表位。方法:通过引入多克隆位点的方法改造表达呈现表达载体pHIE11,并用改造后的质粒表达幽门螺杆菌Ure B串联融合表位,用SDS-PAGE、Western blot和全菌ELISA检测所得到的重组菌。结果:改造的质粒插入序列正确,能够特异性呈现表达Ure B串联融合表位,表达产物的分子量约为60kDa,与预期大小一致。全菌ELISA结果表明Ure B串联融合表位表达于菌体表面。结论:pHIE3N载体能够表面展示呈现Ure B串联融合表位,构建的重组菌为幽门螺杆菌候选疫苗的研发奠定了基础。     

鹦鹉热衣原体B细胞表位的表达及抗原鉴定

利用噬菌体PⅢ蛋白为载体对鹦鹉热衣原体单抗17筛选得到的B细胞抗原表位进行了研究,利用改构后的原核表达载体pQE30,构建含有B细胞表位基因的重组表达质粒,表达的蛋白经ELISA及Western Blot实验证实能够与单抗C17发生特异反应,蛋白免疫动物后得到了抗鹦鹉热衣原体的抗体,验证了所筛选表位的真实性。     

肠毒素大肠杆菌定居因子CS3和肠毒素融合抗原基因在减毒鼠伤寒沙门氏菌中的共表达

不耐热肠毒素（LT）和耐热肠毒素（ST）是产肠毒素大肠杆菌的主要致病因素,CS3为该菌的优势定居因子,是定居因子CFA/Ⅱ菌毛抗原的共有抗原组分。采用基因操作技术将编码CS3和融合肠毒素蛋白基因转化到减毒鼠伤寒沙门氏菌疫苗侯选株X4072中进行表达。用重组菌株口服免疫小鼠后,免疫动物能产生抗CS3、LT和ST的血清抗体。特别有意义的是,所产生的抗ST抗体能中和天然ST的生物活性。这一结果为研究载体疫苗防治肠毒素大肠杆菌腹泻疾病奠定了基础。     

轮状病毒VP4抗原表位在VP6载体蛋白同一位点表达比较研究

目的:评价轮状病毒(RV)VP4两个抗原表位插入VP6载体蛋白同一位点所表达的重组嵌合蛋白免疫学性质及在研制嵌合蛋白疫苗中的意义。方法:采用分子克隆和基因重组技术将RV VP4的两个抗原表位插入到VP6载体蛋白同一位点上,构建重组抗原表达质粒,表达携带不同抗原表位的重组嵌合蛋白,用Western blot和中和试验分析重组嵌合蛋白的抗原反应性和免疫原性。结果:成功构建了两个嵌合蛋白表达质粒,并在大肠杆菌中高效表达;表达的嵌合蛋白可与相应抗体特异性反应;可诱导豚鼠产生特异性血清抗体;抗嵌合蛋白血清抗体可特异性识别载体蛋白VP6F,Wa株病毒的VP6和VP4蛋白,可中和Wa株病毒在MA104细胞上的感染性;结果表明,所构建和表达的两个以VP6为载体的VP4抗原表位嵌合蛋白具有较高抗原反应性和免疫原性;嵌合蛋白携带的VP4抗原表位具有增强载体蛋白免疫原性作用;为研制新型RV重组蛋白疫苗的奠定了较好的基础。     

CTB/CS3融合蛋白与GM1结合能力和免疫原性的分析

免疫霍乱毒素B亚单位（CTB）或肠毒素大肠杆菌（ETEC）定居因子CS3可使人体对ETEC的侵染有保护作用.为探索研制ETEC双组分亚单位疫苗的可行性,利用大肠杆菌诱导表达系统表达了CTB与CS3的融合蛋白（CTB/CS3）.蛋白质印迹结果表明,诱导表达的29 ku蛋白具有CTB和CS3蛋白双重抗原性.经Ni-NTA亲和层析纯化获得重组蛋白CTB/CS3,复性的重组蛋白可以部分形成五聚体并保留了与神经节苷脂GM1的结合能力.动物实验表明,融合蛋白CTB/CS3具有CTB和CS3蛋白的双重免疫原性,同时,CTB的免疫载体作用提高了CS3的免疫强度.     

Characterization of FimA in Porphyromonas gingivalis genotype IV

It has been reported that a large majority of periodontitis patients carry organisms with either type II or IV-fimA, while type I is the most prevalent fimA genotype among Porphyromonas gingivalis-positive healthy adults. Here we report characterization of recombinant fimbrial protein (rFimA) produced in Escherichia coli from genotype IV-fimA. In SDS-PAGE and immunoblot analysis after partial dissociation, type IV-rFimA showed a ladder-like pattern representing oligomeric/polymeric forms of native fimbrial structure. Unlike anti-type I-native fimbriae which can only recognize conformational epitopes of the respective proteins, both anti-type IV-native fimbriae and anti-type IV-rFimA antibodies recognized conformational as well as linear epitopes in type IV-fimbriae. These results suggest that the type IV-rFimA proteins retain the native fimbrial antigenicity and the antigenicity of type IV-fimbriae is different from that of type I-fimbriae.     

Assessing the expression of enterotoxigenic Escherichia coli-specific surface antigens in recombinant strains by transmission electron microscopy and immunolabeling.

Infections with enterotoxigenic Escherichia coli (ETEC) are a major cause of travelers' diarrhea worldwide. Colonization of the small intestine mucosa is dependent on specific colonization factor antigens (CFA) and coli surface (CS) antigens. CFA/1, CS3, and CS6 are the most prevalent fimbrial antigens found in clinical isolates. The goal of our study was to visualize the morphology of CS3 and CS6 fimbriae in wild-type and recombinant E. coli strains by means of transmission electron microscopy in conjunction with negative staining and immunolabeling. Corresponding ETEC genes were cloned into E. coli K12 strain DH10B. Expression of fimbriae was dependent on culture conditions and sample handling. Specific immunolabeling of fimbriae unequivocally demonstrated the presence of all types of surface antigens investigated. Negative staining was effective in revealing CS3 but not CS6. In addition, this technique clearly demonstrated differences in the morphology of genetically and immunologically identical CS3 surface antigens in wild-type and recombinant strains. This paper provides a basis for the assessment of recombinant vaccines.     

毒素源性大肠杆菌定居因子抗原CS6基因的克隆

通过构建人源毒素源性大肠杆菌野生株E519/66A大质粒的基因文库,成功地筛选出能表达定居因子抗原CS6菌毛的阳性克隆,初步确定了克隆DNA片段的限制性内切酶图谱。CS6抗原的编码和调控基因集中在一大小为4.6kb的DNA区段中,该片段能产生两种分子量大小不同、但抗原反应交叉的菌毛蛋白。本研究获得的CS6抗原阳性的重组菌株可用于人源ETEC多价疫苗的研制,克隆的基因片段亦可作为研究CS6菌毛蛋白基因表达及调控的基础。     

CS3抗原基因的表达及纤毛装配元件的研究

在肠毒素大肠杆菌(ETEC)的已知定居因子中,CS3是临床分离株中最常见的抗原之一。为了研究CS3纤毛装配的基本元件,绘制了CS3亚基结构基因和辅助蛋白编码区的限制酶谱。通过亚克隆的亚基基因和不同辅助蛋白基因之间的互补性表达结果,确定了CS3纤毛装配所需要的辅助蛋白的DNA功能片段。微细胞分析结果显示,CS3基因的有效表达和纤毛装配至少需要6条蛋白多肽,分子量分别为(×10~3)15、17、24、27、48和90。除了15×10~3/17×10~3的蛋白多肽为CS3亚基外,其余的蛋白多肽参与CS3亚基的转运及纤毛的装配。根据以上结果初步确定了上述相关基因的相对位置。     

Morphological and immunocytochemical analysis of Escherichia coli-specific surface antigens in wildtype strains and in recombinant Vibrio cholerae

Adhesion is the first step in the pathogenesis of enterotoxigenic Escherichia coli infections. The genes encoding the most prevalent adhesion factors CFA/I, CS3 and CS6 were cloned into Vibrio cholerae strain CVD 103–HgR and expression of fimbriae was investigated in wildtype and recombinant strains by transmission electron microscopy in conjunction with immunolabelling and negative staining. Negative staining was effective in revealing CFA/I and CS3, but not CS6. Although morphology of fimbriae differed between wildtype and recombinant strains, corresponding surface antigens were recognized by specific antibodies. The present study provides evidence that ETEC-specific fimbriae can adequately be expressed in an attenuated V. cholerae vaccine strain and that immunoelectron microscopy is a critical tool to validate the surface expression of antigens in view of their possible suitability for recombinant vaccines.     

The fimbriae of human enterotoxigenic Escherichia coli strain 334 are related to CS5 fimbriae

Escherichia coli strain 334 is a human enterotoxigenic strain of serotype O15:H11 which had previously been shown to produce 'attachment pili'. These fimbriae were compared with other colonization factors. From strain 334 a mannose-resistant haemagglutination positive colony 334A and a mannose-resistant haemagglutination negative variant 334C were isolated. By electron microscopy the fimbriae of strain 334A were shown to have a helical structure resembling coli-surface-associated antigen (CS5) fimbriae. An antiserum was raised to strain 334A and absorbed with a fimbriae-negative variant of that strain, 334C. By immuno-electron microscopy this antiserum was shown to coat fimbriae of strain 334A but not CS5 fimbriae produced by strain E17018A. Conversely, CS5 antiserum did not coat the fimbriae produced by strain 334A. No antigenic cross-reaction was detected between these intact fimbriae when anti-strain 334A serum and CS5 antiserum were used in immunodiffusion tests. By enzyme-linked immunosorbent assays (ELISAs) the fimbriae of strain 334A were shown to be antigenically unrelated to most other human ETEC adhesins, namely colonization factor antigens (CFA/I, CFA/III and CFA/IV), coli-surface-associated antigens (CS1, CS2, CS3, CS4, CS6 and CS17) and putative colonization factors (PCFO159:H4 and PCFO166). However, a heated suspension of strain 334A reacted weakly with CS5 antiserum in an ELISA. By SDS-PAGE the fimbriae of strain 334A were shown to consist of subunits of similar size to CS5 subunits, that is about 21.5 kDa. Western immunoblotting revealed that the subunits of 334A and CS5 fimbriae shared common epitopes.(ABSTRACT TRUNCATED AT 250 WORDS)     

CS3 fimbriae of enterotoxigenic Escherichia coli as chimeric expression carriers of heterologous antigenic determinants

CS3 fimbriae, which are the strong immunogen, are produced by human enterotoxigenic Escherichia coli (ETEC). The possibility of using CS3 as a carrier of foreign antigenic determinants was investigated. A SacⅡ site sequence was inserted into the structural gene of CS3 subunit by site-specific mutagenesis based on analyzing and predicting the properties of the proteins. A recombinant strain expressing CS3/CTP3 hybrid fimbriae was constructed by inserting the sequence encoding CTP3 into the SacII site created by directed mutagenesis in the structural gene of CS3 subunit and transforming the recombinant plasmid into the host of DH5α. The result of SDS-PAGE showed that the hybrid CS3/CTP3 molecules were the fusion proteins with molecular masses of about 18.5 ku. Inoculating mice orally and intraperitoneally showed that both antibodies against CS3 and CTP3 were elicited. These results indicate that CS3 pili could be an exposure vector for heterologous antigenic determinants and become a powerful tool for the development of oral vaccines directed against mucosal pathogens.     

CS3 fimbriae of enterotoxigenicEscherichia coli as chimeric expression carriers of heterologous antigenic determinants

CS3 fimbriae, which are the strong immunogen, are produced by human enterotoxigenicEscherichia coli (ETEC). The possibility of using CS3 as a carrier of foreign antigenic determinants was investigated. A SacII site sequence was inserted into the structural gene of CS3 subunit by site-specific mutagenesis based on analyzing and predicting the properties of the proteins. A recombinant strain expressing CS3/CTP3 hybrid fimbriae was constructed by inserting the sequence encoding CTP3 into the SacII site created by directed mutagenesis in the structural gene of CS3 subunit and transforming the recombinant plasmid into the host of DH5α. The result of SDS-PAGE showed that the hybrid CS3/CTP3 molecules were the fusion proteins with molecular masses of about 18.5 ku. Inoculating mice orally and intraperitoneally showed that both antibodies against CS3 and CTP3 were elicited. These results indicate that CS3 pili could be an exposure vector for heterologous antigenic determinants and become a powerful tool for the development of oral vaccines directed against mucosal pathogens.